Cite

MLA Citation

    Fumiko Nakazeki et al.. “MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons.” Clinical science, vol. 133, 2019, pp. 583–595. http://access.bl.uk/ark:/81055/vdc_100088837380.0x00005b
  
Back to record